Antimicrobial agent | No. of resistant isolates | P | ||
---|---|---|---|---|
Environmental source (N = 22) | Patient source (N = 30) | Total (N = 52) | ||
Ampicillin | 9 (41%) | 19 (63%) | 28 (54%) | 0.37 |
Cefotaxime | 1 (5%) | 3 (10%) | 4 (8%) | – |
ESBL | 1 (5%) | 3 (10%) | 4 (8%) | – |
Nalidixic acid | 16 (73%) | 28 (93%) | 44 (85%) | 0.55 |
Ciprofloxacin | 4 (18%) | 6 (20%) | 10 (19%) | – |
Gentamicin | 3 (14%) | 3 (10%) | 6 (11%) | – |
Chloramphenicol | 10 (45%) | 19 (63%) | 29 (56%) | 0.43 |
Tetracycline | 15 (68%) | 20 (67%) | 35 (67%) | 0.96 |
Trimethoprim-sulfamethoxazole | 18 (82%) | 22 (73%) | 40 (77%) | 0.80 |
MDR* | 7 (32%) | 18 (60%) | 25 (48%) | 0.22 |
Total events | 84 (38%) | 141 (47%) | 225 (44%) | 0.04 |